Paradoxical effects of two theta-defensins on HIV type 1 infection

AIDS Research and Human Retroviruses

Volumn 23, Issue 4, 2007, Pages 508-514

  Wang, Qiuwei ^a   Wang, Wei ^a   Zheng, Junying ^a   Tabibian, Sina ^a   Xie, Yiming ^a   Song, Jun ^a   Waring, Alan J ^a   Chiu, Robert ^a   Yang, Otto O ^a   Chen, Irvin S Y ^a   Lehrer, Robert I ^a   Pang, Shen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; GREEN FLUORESCENT PROTEIN; RETROCYCLIN 1; RETRORETROCYCLIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL CLONE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; DEFENSINS; EPITHELIAL CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY; NEUROGLIA;

EID: 34247855878     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0119     Document Type: Article

References (20)

1. Cole AM, Wang W, Waring AJ, and Lehrer RI: Retrocyclins: Using past as prologue. Curr Protein Pept Sci 2004;5:373-381.
2. Selsted ME: Theta-defensins: Cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins. Curr Protein Pept Sci 2004;5:365-371.
3. Selsted ME and Ouellette AJ: Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005;6:551-557.
4. Tang YQ, Yuan J, Osapay G, et al.: A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 1999;286:498-502.
5. Cole AM, Hong T, Boo LM, et al.: Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci USA 2002;99:1813-1818.
6. Munk C, Wei G, Yang OO, et al.: The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses 2003;19:875-881.
7. Wang W, Owen SM, Rudolph DL, et al.: Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol 2004; 173:515-520.
8. Owen SM, Rudolph DL, Wang W, et al.: RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2004;20:1157-1165.
9. Koyanagi Y, Miles S, Mitsuyasu RT, et al.: Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987;236:819-822.
10. Gao F, Robertson DL, Carruthers CD, et al.: A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998;72:5680-5698.
11. Pang S, Yu D, An DS, et al.: Human immunodeficiency virus Env-independent infection of human CD4(-) cells. J Virol 2000;74: 10994-11000.
12. Chow YH, Yu D, Zheng JY, et al.: gp120-independent infection of CD4- epithelial cells and CD4+ T-cells by HIV-1. J Acquir Immune Defic Syndr 2002;30:1-8.
13. Zheng JY, Yang OO, Xie Y, Chen IS, and Pang S: Ethanol stimulation of HIV infection of oral epithelial cells. J Acquir Immune Defic Syndr 2004;37:1445-1453.
14. Zheng J, Xie Y, Wang Q, Campbell R, et al.: gp120-independent HIV infection of cells derived from the female reproductive tract, brain, and colon. J Acquir Immune Defic Syndr 2006;43:127-136.
15. Esser U, Speck RF, Deen KC, Atchison RE, Sweet R, and Goldsmith MA: Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1. AIDS Res Hum Retroviruses 2000;16:1845-1854.
16. Wang W, Cole AM, Hong T, Waring AJ, and Lehrer RI: Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol 2003; 170:4708-4716.
17. Gallo SA, Wang W, Rawat SS, et al.: Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem 2006;281;18787-18792.
18. Cole AL, Yang OO, Warren AD, Waring AJ, Lehrer RI, and Cole AM: HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41. J Immunol 2006; 176:6900-6905.
19. Yasin B, Wang W, Pang M, et al.: Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 2004;78:5147-5156.
20. Leikina E, Delanoe-Ayari H, Melikov K, et al.: Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 2005;6:995-1001.